May 26, 2011
Common transplant drug inhibits breast cancer growth, UNC laboratory study shows
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.